Moderna Reports First Quarter 2022 Financial Results and Provides Business Updates phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
First quarter 2022 revenues of $6.1 billion; GAAP net-income of $3.7 billion and GAAP diluted EPS of $8.58Moderna reiterates its 2022 signed advance purchase agreements of approximately $21 billionCompany
Scientists Are Working on mRNA Vaccines for HIV, Flu, Cancer and More Advertisement
Scientists Are Working on mRNA Vaccines for HIV, Flu, Cancer and More
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis. Advertisement
The same messenger RNA (mRNA) technology used in the Moderna and Pfizer/BioNTech coronavirus vaccines, which are around 95% effective at preventing symptomatic COVID-19, could potentially be used to prevent or treat a wide variety of other diseases.
Moderna recently announced that it has started new programs to design mRNA vaccines for HIV, seasonal influenza and Nipah virus, adding to the company’s development portfolio for several other viral diseases and cancer.